AHNS Presidential Award: Novel Therapeutic Targets and Combinations in Head and Neck Cancer
Funds translational research using genomics and mechanistic studies to identify new therapeutic targets and combinations for head and neck cancer.
Funder: American Academy of Otolaryngology - Head and Neck Surgery
Due Dates (Anticipated): December 2026 (Letter of Intent) | January 2027 (Full Application)
Funding Amounts: $15,000 maximum for 12 months (non-renewable)
Summary: Supports innovative, translational research to identify new therapeutic targets and combinations in head and neck cancer.
Description
This grant funds research projects focused on discovering novel therapeutic targets and rational combinations in head and neck cancer. The program encourages projects that use genomics, immune profiling, mechanistic studies, and analyses of human tissues (preferred) or animal models to identify new therapeutic avenues based on biological dependencies in tumors or their microenvironments. The research should have a clear translational focus, ideally fostering interdisciplinary collaboration and laying the groundwork for larger, future funding.
